98%
921
2 minutes
20
There are limited and discrepant data on prostate cancer (PCa) and vitamin D. We investigated changes in three vitamin D metabolites in PCa patients after prostatectomy with zoledronic acid (ZA) treatment regarding their metastasis statuses over four years. In 32 patients from the ZEUS trial, 25(OH)D, 24,25(OH)D, and 1,25(OH)D were measured with liquid chromatography coupled with tandem mass spectrometry at four time points. All the patients received daily calcium and vitamin D. Bone metastases were detected in 7 of the 17 ZA-treated patients and in 5 of the 15 controls (without ZA), without differences between the groups ( = 0.725). While 25(OH)D and 24,25(OH)D increased significantly after the study's start, with following constant values, the 1,25(OH)D concentrations remained unchanged. ZA treatment did not change the levels of the three metabolites. 25(OH)D and 24,25(OH)D were not associated with the development of bone metastases. In contrast, 1,25(OH)D was also higher in patients with bone metastasis before the study's start. Thus, in high-risk PCa patients after prostatectomy, 25(OH)D, 24,25(OH)D, and 1,25(OH)D were not affected by supportive ZA treatment or by the development of metastasis over four years, with the exception of 1,25(OH)D, which was constantly higher in metastatic patients. There might be potential prognostic value if the results can be confirmed.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946001 | PMC |
http://dx.doi.org/10.3390/cancers14061560 | DOI Listing |
Br J Dermatol
September 2025
Population Health Program, QIMR Berghofer, Brisbane, Australia.
Background: Sunscreen reduces vitamin D production in experimental studies. It is uncertain whether this translates to 'real-world' settings.
Objectives: We aimed to dtermine if routinely applying high-SPF sunscreen for one year reduces serum 25-hydroxyvitamin D [25(OH)D] concentration.
Front Nutr
August 2025
Department of Developmental and Behavioral Pediatrics, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Pudong, Shanghai, China.
Background: Emerging evidence suggests vitamin D plays a dual role in immune regulation, yet its interplay with genetic susceptibility in early-life allergy development remains poorly understood. This prospective cohort study investigated whether cord blood 25-hydroxyvitamin D [25(OH)D] levels interact with immunoregulatory gene variants to influence childhood food allergy risk.
Methods: A total of 1,049 mother-infant pairs from the Shanghai Allergy Cohort were stratified by cord blood 25(OH)D concentrations (<15, 15-25, >25 ng/mL).
Front Med (Lausanne)
August 2025
Internal Clinic, 3rd Medical Faculty, Charles University and University Thomayer Hospital, Prague, Czechia.
Objectives: The absorption of conventional cholecalciferol may be impaired in patients with inflammatory bowel disease (IBD). The bioavailability and optimal dosing of buccally absorbable nanoemulsion vitamin D in this population remain unclear. This study aimed to compare the effects of buccal nanoemulsion and conventional oral vitamin D supplementation on serum 25-hydroxyvitamin D (25OHD) levels in patients with IBD.
View Article and Find Full Text PDFCureus
August 2025
Biochemistry, Liaquat University of Medical and Health Sciences, Karachi, PAK.
Background: Vitamin D insufficiency is increasingly recognized as a significant and underlying contributor to a wide range of musculoskeletal disorders, particularly in gastrointestinal (GI) and endocrine health. The study aims to determine the clinical relationship between vitamin D status and the severity of GI symptoms, while also assessing the impact of related endocrine disturbances.
Methods: A cross-sectional study was conducted involving 120 adult patients with GI problems, including constipation, bloating, irritable bowel syndrome (IBS), and dyspepsia in a tertiary care hospital over a six-month duration.
Int J Gen Med
August 2025
Department of Pediatrics, Fujian Medical University Union Hospital, Fujian, 350000, People's Republic of China.
Purpose: To investigated the effect of pediatric massage combined with comprehensive management on height improvement in children with short stature.
Patients And Methods: This retrospective analysis included medical records of 80 children diagnosed with short stature, who received treatment at Wuhu Hospital of Traditional Chinese Medicine between April 2022 and April 2023. According to the recorded treatment modalities, patients were divided into two groups: the control group received standard comprehensive management (including psychological health guidance, diet, sleep, exercise), while the massage group received additional pediatric syndrome-based massage therapy alongside comprehensive treatment.